New Acute Myeloid Leukemia Study Findings Has Been Reported by a Researcher at University of Maryland (Deep PIM kinase substrate profiling reveals new rational co-therapeutic strategies for acute myeloid leukemia).

A recent study conducted at the University of Maryland has revealed new findings about acute myeloid leukemia (AML). The study focused on the role of PIM kinases in AML and their potential as therapeutic targets. The researchers found that inhibiting PIM kinases in combination with other drugs targeting RNA splicing and rRNA processing could effectively kill AML cells. These findings provide valuable insights into the functions of PIM kinases and suggest new co-therapeutic strategies for treating AML. [Extracted from the article]